Splicing Machinery Is Impaired in Oral Squamous Cell Carcinomas and Linked to Key Pathophysiological Features
International Journal of Molecular Sciences · 25.06.2024 · 25 (13) · 6929
DOI: 10.3390/ijms25136929 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.06.2024. Verfasst von Alba Sanjuan-Sanjuan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Maimonides Biomedical Research Institute of Cordoba (IMIBIC), 14004 Cordoba, Spain. Hauptthemen laut MEDLINE: Mouth Neoplasms, Carcinoma, Squamous Cell, Cell Proliferation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Innovation of Spain, Instituto de Salud Carlos III, European Union.
Abstract (Originalsprache)
Alternative splicing dysregulation is an emerging cancer hallmark, potentially serving as a source of novel diagnostic, prognostic, or therapeutic tools. Inhibitors of the activity of the splicing machinery can exert antitumoral effects in cancer cells. We aimed to characterize the splicing machinery (SM) components in oral squamous cell carcinoma (OSCC) and to evaluate the direct impact of the inhibition of SM-activity on OSCC-cells. The expression of 59 SM-components was assessed using a prospective case-control study of tumor and healthy samples from 37 OSCC patients, and the relationship with clinical and histopathological features was assessed. The direct effect of pladienolide-B (SM-inhibitor) on the proliferation rate of primary OSCC cell cultures was evaluated. A significant dysregulation in several SM components was found in OSCC vs. adjacent-healthy tissues [i.e., 12 out of 59 (20%)], and their expression was associated with clinical and histopathological features of less aggressiveness and overall survival. Pladienolide-B treatment significantly decreased OSCC-cell proliferation. Our data reveal a significantly altered expression of several SM-components and link it to pathophysiological features, reinforcing a potential clinical and pathophysiological relevance of the SM dysregulation in OSCC. The inhibition of SM-activity might be a therapeutic avenue in OSCC, offering a clinically relevant opportunity to be explored.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Maimonides Biomedical Research Institute of Cordoba (IMIBIC), 14004 Cordoba, Spain.
- Reina Sofia University Hospital (HURS), 14004 Cordoba, Spain.
- Oral and Maxillofacial Surgery Department, HURS, 14004 Cordoba, Spain.
- Oral and Maxillofacial Surgery Department, CAMC Hospital, Charleston, WV 25301, USA.
- Department of Cell Biology, Physiology, and Immunology, University of Cordoba, 14014 Cordoba, Spain.
- CIBER Physiopathology of Obesity and Nutrition (CIBERobn), 14004 Cordoba, Spain.
ORCID-Profile: Alba Sanjuan-Sanjuan, Mabel Falguera Uceda, Raúl M Luque
Förderung
- Ministry of Science and Innovation of Spain
- Instituto de Salud Carlos III
- European Union
- Junta de Andalucia
- CIBERobn
Zitieren
APA
Sanjuan-Sanjuan, A., Alors-Perez, E., Sanchez-Frías, M., Monserrat-Barbudo, J. A., Falguera Uceda, M., Heredero-Jung, S., & Luque, R. M. (2024). Splicing Machinery Is Impaired in Oral Squamous Cell Carcinomas and Linked to Key Pathophysiological Features. International Journal of Molecular Sciences, 25(13), 6929. https://doi.org/10.3390/ijms25136929
Vancouver
Sanjuan-Sanjuan A, Alors-Perez E, Sanchez-Frías M, Monserrat-Barbudo JA, Falguera Uceda M, Heredero-Jung S, et al. Splicing Machinery Is Impaired in Oral Squamous Cell Carcinomas and Linked to Key Pathophysiological Features. International Journal of Molecular Sciences. 2024;25(13):6929. doi:10.3390/ijms25136929
BibTeX
@article{SanjuanSanjuan2024,
author = {Sanjuan-Sanjuan, Alba and Alors-Perez, Emilia and Sanchez-Frías, Marina and Monserrat-Barbudo, José A and Falguera Uceda, Mabel and Heredero-Jung, Susana and Luque, Raúl M},
title = {Splicing Machinery Is Impaired in Oral Squamous Cell Carcinomas and Linked to Key Pathophysiological Features},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {13},
pages = {6929},
doi = {10.3390/ijms25136929}
}
EUVIMED